Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

Biocidal product factsheet - Last updated: 26/02/2024

Biocidal Product details

Trade name:

XYLOLIN

Product-type:

PT08

Active Substance details

IUPAC name:

1-{[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl}-1H-1,2,4-triazole

EC number:

262-104-4

CAS number:

60207-90-1

BAS number:

48

The Active Substance is a candidate for substitution

IUPAC name:

3-iodoprop-2-yn-1-yl N-butylcarbamate

EC number:

259-627-5

CAS number:

55406-53-6

BAS number:

39

Substance name:

IUPAC name:

(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate

EC number:

258-067-9

CAS number:

52645-53-1

BAS number:

1342

The Active Substance is a candidate for substitution

Authorised
map
Authorisation information

Authorisation type:

National authorisation

Legal act:

Assessment reports:

1 authorisation in the product cluster
Authorisation number SPC Decisions

XYLOLIN

PT08

Greece

STANCOLAC FOTIOU SA GR-0020987-0000 ΤΠ8-0128 20/06/2019 20/01/2028

Single SPC  (el)

XYLOLIN_VAR JANUARY 2020.pdf (el)

XYLOLIN SBP.pdf (el)

XYLOLIN_AMEND EXPIRY DATE.pdf (el)

Authorised
Reference authorisation
Trade name: XYLOLIN
Authorisation number: GR-0020987-0000| Market area: Greece

3 assessment records available

Amendment of national authorisation

Evaluating authority:

Greece

Conclusion date:

13/04/2021

Validity of authorisation

Start date:

20/06/2019

End date:

20/01/2028

SPC

Single SPC  (el)

Amendment of national authorisation

Evaluating authority:

Greece

Conclusion date:

30/01/2020

Validity of authorisation

Start date:

20/06/2019

End date:

20/06/2029

SPC

SPC not available

Application of national authorisation

Evaluating authority:

Greece

Conclusion date:

04/07/2019

Validity of authorisation

Start date:

20/06/2019

End date:

20/06/2029

SPC

SPC not available